Abstract
This article discusses the genetic counseling protocols which were developed and counseling issues that have arisen in the first 2 years of evaluating a large kindred with a BRCA1 mutation. The rationale for the development of the genetic counseling protocols and specific genetic counseling visual aids are presented and discussed. The protocols and counseling aids can serve as models for other programs offering cancer susceptibility testing. The observations of study counselors about study subject concerns and responses to genetic testing at the time of the pretest and posttest counseling sessions are presented.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Biesecker BB, Boehnke M, Calzone K, Markel, DS, Garber JE, Collins FS, Weber BL (1993) Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269(15):1970–1974.
Botkin J, Croyle R, Smith K, Baty B, Lerman C, Goldgar D, Ward J, Flick B, Nash J (1996) A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. JNCI 88(13):872–882.
Cavenee WK, White RL (1995) The genetic basis of cancer. Scientific American March, p 77.
Craufurd D, Dodge A, Kerzin-Storrar L, Harris R (1989) Uptake of presymptomatic predictive testing for Huntington disease. Lancet 603–605.
Croyle RT, Smith KR, Botkin JR, Baty B, Nash J (1996) Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol (in press).
Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265–271.
Ford, D, Easton D, Bishop DT, Narod SA, Goldgar DE, and the Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343:692–295.
Goldgar DE, Fields P, Lewis CM, Tran TD, Cannon-Albright LA, Ward JH, Swensen J, Skolnick MH (1994) A large kindred with 17q-linked breast and ovarian cancer: Genetic, phenotypic, and genealogical analysis. JNCI 86(3):200–209.
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689.
Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL (1995) Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA 273:577–585.
Kelly PT (1991) Understanding Breast Cancer Risk. Philadelphia: Temple University Press.
King MC, Rowell S, Love SM (1993) Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 269(15):1975–1980.
Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H (1996) BRCA1 testing in families with breast-ovarian cancer: A prospective study of patient decision-making and outcomes. JAMA 275:1885–1892.
Miki Y, Swensen J, Shattuck-Eidens D, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71.
NIH Consensus Development Panel on Ovarian Cancer (1995) Ovarian cancer: Screening, treatment and follow-up. JAMA 273:491–497.
Peters J (1992) When a history of breast cancer is identified during a counseling session. Perspect Genet Counsel 14(3):2–3.
Peters J, Stopfer J (1996) Role of the genetic counselor in familial cancer. Oncology 10:159–175.
Puck SM, Fleming JP (1986) Genetics, Environment & Your Baby. A Workbook for Parents to Be. Santa Fe, NM: Vivigen, pp 21–26.
Richards MPM, Hallowell N, Green JM, Murton F, Statham H (1995) Counseling families with hereditary breast and ovarian cancer: A psychosocial perspective. J Genet Counsel 4(3):219–233.
Schneider KA (1994) Counseling About Cancer: Strategies for Genetics Counselors. Dennisport, MA: Graphic Illusions.
Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, Brody L, Friedman L, Ostermeyer E, Szabo C, King M-C, Jhanwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne M, Black D, Boyd M, Steel M, Ingles S, Haile R, Lindblom A, Olsson H, Borg A, Bishop DT, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick MH, Goldgar DE (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273(7):535–541.
Utah Cancer Registry, SEER Contract #N01CN05222.
Wiggins S, Whyte P, Huggins M, Adam S, Theilmann J, Bloch M, Sheps SB, Schechter MT, Hayden MR (1992) The psychological consequences of predictive testing for Huntington's disease. N Eng J Med 327:1401–1405.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baty, B.J., Venne, V.L., McDonald, J. et al. BRCA1 Testing: Genetic Counseling Protocol Development and Counseling Issues. Journal of Genetic Counseling 6, 223–244 (1997). https://doi.org/10.1023/A:1025620404473
Issue Date:
DOI: https://doi.org/10.1023/A:1025620404473